Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment ...

Addressing all aspects of healthcare maintenance in ulcerative colitis (UC) — one of two major types of ... Patients on ...

SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

"Since the first biologic treatment for ulcerative colitis was introduced in 2005, 11 advanced therapies have become ...

The new ulcerative colitis (UC) triumvirate in Johnson & Johnson’s Tremfya ... are also in the space. There are many more ...

The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...

The clinical management of ulcerative colitis (UC) involves first treating ... may be candidates for treatment with thiopurines and/or biologics in the early stages of UC. Calcineurin inhibitors ...

If you have ulcerative colitis (UC), you may already be taking medications prescribed by your doctor to address symptoms and help stave off flare-ups. While biologic and small molecule medications ...

or other biologics,” she continued. “These are key goals in the treatment of ulcerative colitis to minimize disease-related disability.” 87% of those with Crohn’s have clinical remission ...